World-class
Scientific Advisory

Work with Richmond Pharmacology and trust your experience will be personal and truly strategic.

Dr T.J Von Oertzen - Consultant Neurologist and Epileptologist (MD., F.R.C.P.)

Dr. von Oertzen studied medicine at Rheinische-Friedrich-Wilhelm University, Germany and completed his final year at University College of London in 1995. He was supervising consultant in Europe's largest centre for presurgical evaluation in epilepsy, Department of Epileptology, at the University of Bonn where he gained major experience in all aspects of blackouts, epilepsy, non epileptic attack disorders and other conditions. Dr. von Oertzen is fully trained in Neurophysiology, particularly in EEG (electroencephalogram recording of brainwaves) of both surface and intracranial recordings.

Dr. von Oertzen has been appointed as the lead clinician for the epilepsy service at the Atkinson Morley Neuroscience Centre, St George's Hospital, since 2004. At present, he is holding specialist clinics for first fits and blackouts, complex cases and people with drug refractory epilepsy including pre-surgical assessment. He holds an Honorary Senior Lecturer post at St George's University of London is also honorary Consultant Neurologist at Kingston Hospital.

Dr. von Oertzen has presented clinical and research data on national and international conferences. He has frequently published in medical journals and contributed to definite books about epilepsy. He is involved in raising awareness for epilepsy and providing continuous medical education for medical professionals.

Back to experts

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
View event

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020
Richmond Pharmacology early phase drug development update.
Read more

Dr Jorg Taubel, CEO of Richmond Pharmacology, features on the PM Live website, discussing clincial trials and COVID-19

August 11, 2020
Dr Jorg Taubel discusses some of the steps taken at Richmond Pharmacology to ensure clinical trials can continue to operate at a high standard throughout the COVID-19 pandemic.
Read more